N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease.
Lucy K ShewellChristopher J DayJamie R KutasovicJodie L AbrahamsJing WangJessica PooleColleen NilandKaltin FergusonJodi M SaunusSunil R LakhaniMark von ItzsteinJames C PatonAdrienne W PatonMichael P JenningsPublished in: BMC cancer (2022)
Neu5Gc serum biomarkers are a promising new tool for early detection and disease monitoring for breast cancer that may complement current imaging- and biopsy-based approaches.